John Hayes, co-founder and chief technology officer of BlackRidge Technology International, Inc. (OTCQB: BRTI), a leading provider of next-generation cyber defense solutions, has been named...

Primmune Therapeutics today announced that it will present preclinical data on a novel series of toll-like receptor 7 (TLR7) agonists engineered for systemic activation of innate immunity at the...

Geom Therapeutics, Inc., a privately held biopharmaceutical company focused on the development of novel antibiotics for multidrug-resistant (MDR) gram-negative infections, today announced upcoming...

As laboratories increasingly look to bring advanced molecular testing in-house, the results of a new retrospective clinical research study show that tumor mutation burden (TMB) assessments...

GenScript®, the world's leading gene synthesis provider, today at the American Association for Cancer Research launched a single-stranded DNA (ssDNA) service. The new service offers researchers...